Prognosis in women with interval breast cancer: population based observational cohort study
- PMID: 23160783
- PMCID: PMC3500095
- DOI: 10.1136/bmj.e7536
Prognosis in women with interval breast cancer: population based observational cohort study
Abstract
Objective: To compare the prognosis in women with interval breast cancer (cancer detected after a normal screening mammogram and before the next scheduled mammogram) with breast cancer detected among women not yet invited to mammography screening (non-screened).
Design: Population based observational study.
Setting: Norwegian breast cancer screening programme, implemented in different counties from 1996 to 2005.
Participants: 7116 women with a diagnosis of breast cancer at age 50 to 72 years; 1816 had interval breast cancer and 5300 had a diagnosis of breast cancer but had not yet been invited to screening.
Main outcome measures: Characteristics of the breast tumours, and survival of the women using Kaplan Meier curves and multivariable Cox proportional hazard models.
Results: Although interval cancers on average were slightly larger than the cancers in women not invited to screening, the histological type or status of axillary lymph nodes did not differ noticeably between the two groups. Among interval cancers, there were no appreciable trends in size, nodal status, grade, or hormone receptor positivity associated with time since the last normal mammogram as a marker of growth rate. After 10 years of follow-up, the survival rates were 79.1% (95% confidence interval 75.4% to 82.3%) among women with interval cancers and 76.8% (75.3% to 78.2%) among women in the non-screened cancer group (hazard ratio 0.98, 95% confidence interval 0.84 to 1.15; P=0.53). Analyses stratified by time since last normal mammogram, age at diagnosis, or screening round showed similar results.
Conclusion: The prognosis of women with interval breast cancers was the same as that of women with breast cancers diagnosed without mammography screening.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Similar articles
-
Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.JAMA Netw Open. 2020 Jun 1;3(6):e207227. doi: 10.1001/jamanetworkopen.2020.7227. JAMA Netw Open. 2020. PMID: 32602908 Free PMC article.
-
Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.Br J Cancer. 2017 Mar 14;116(6):828-839. doi: 10.1038/bjc.2017.6. Epub 2017 Feb 9. Br J Cancer. 2017. PMID: 28183141 Free PMC article.
-
Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.Lancet Oncol. 2011 Nov;12(12):1118-24. doi: 10.1016/S1470-2045(11)70250-9. Epub 2011 Oct 11. Lancet Oncol. 2011. PMID: 21996169
-
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.APMIS Suppl. 1998;83:1-44. APMIS Suppl. 1998. PMID: 9850674
-
Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study.Breast Cancer Res. 2009;11(4):R44. doi: 10.1186/bcr2331. Epub 2009 Jul 6. Breast Cancer Res. 2009. PMID: 19575807 Free PMC article. Clinical Trial.
Cited by
-
External Validation of a Commercial Artificial Intelligence Algorithm on a Diverse Population for Detection of False Negative Breast Cancers.J Breast Imaging. 2025 Jan 25;7(1):16-26. doi: 10.1093/jbi/wbae058. J Breast Imaging. 2025. PMID: 39401322
-
Breast cancer survival and prognosis by screening history.Br J Cancer. 2014 Feb 4;110(3):556-9. doi: 10.1038/bjc.2013.732. Epub 2013 Dec 3. Br J Cancer. 2014. PMID: 24300976 Free PMC article.
-
The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening.NPJ Breast Cancer. 2017 Apr 13;3:12. doi: 10.1038/s41523-017-0014-x. eCollection 2017. NPJ Breast Cancer. 2017. PMID: 28649652 Free PMC article.
-
Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.BMC Med. 2019 Jan 31;17(1):24. doi: 10.1186/s12916-019-1252-6. BMC Med. 2019. PMID: 30700300 Free PMC article.
-
Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer.JAMA Netw Open. 2024 May 1;7(5):e2411927. doi: 10.1001/jamanetworkopen.2024.11927. JAMA Netw Open. 2024. PMID: 38767918 Free PMC article.
References
-
- Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol BiomarkersPrev 2005;14:1108-12. - PubMed
-
- Gilliand FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 2000;92:743-9. - PubMed
-
- Sihto H, Lundin J, Lehtimäki T. Molecular subtypes of breast cancer detected in mammography screening and outside of screening. Clin Cancer Res 2008;14:4103-10. - PubMed
-
- Zackrisson S, Janzon L, Manjer J, Andersson I. Improved survival rate for women with interval breast cancer—results from the breast cancer screening programme in Malmö, Sweden 1976-1999. J Med Screen 2007;14:138-43. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical